AT258875B - Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate - Google Patents

Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Info

Publication number
AT258875B
AT258875B AT956163A AT956163A AT258875B AT 258875 B AT258875 B AT 258875B AT 956163 A AT956163 A AT 956163A AT 956163 A AT956163 A AT 956163A AT 258875 B AT258875 B AT 258875B
Authority
AT
Austria
Prior art keywords
preparation
new
aminopropionamide
derivatives
aminopropionamide derivatives
Prior art date
Application number
AT956163A
Other languages
German (de)
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of AT258875B publication Critical patent/AT258875B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Paper (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT956163A 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate AT258875B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1414962 1962-12-01

Publications (1)

Publication Number Publication Date
AT258875B true AT258875B (de) 1967-12-11

Family

ID=4398397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT956163A AT258875B (de) 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Country Status (3)

Country Link
AT (1) AT258875B (en:Method)
BE (1) BE640639A (en:Method)
GB (1) GB1072118A (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664848A (en) 1982-12-23 1987-05-12 The Procter & Gamble Company Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties
AU2006259415B2 (en) 2005-06-15 2012-08-30 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
MX2011004859A (es) 2008-11-07 2011-08-03 Massachusetts Inst Technology Lipidoides de aminoalcohol y usos de los mismos.
NZ716192A (en) 2009-12-01 2017-07-28 Shire Human Genetic Therapies Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
EP2609135A4 (en) 2010-08-26 2015-05-20 Massachusetts Inst Technology POLY (BETA AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF
WO2012135025A2 (en) 2011-03-28 2012-10-04 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
RS59037B1 (sr) 2011-06-08 2019-08-30 Translate Bio Inc Kompozicije lipidnih nanočestica i postupci za isporuku irnk
EP3536787A1 (en) 2012-06-08 2019-09-11 Translate Bio, Inc. Nuclease resistant polynucleotides and uses thereof
CA2884870C (en) 2012-08-13 2022-03-29 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
WO2014152966A1 (en) 2013-03-14 2014-09-25 Shire Human Genetic Therapies, Inc. Methods for purification of messenger rna
MX393573B (es) 2013-03-14 2025-03-21 Shire Human Genetic Therapies Composiciones de acido ribonucleico mensajero del regulador transmembrana de fibrosis quistica y metodos y usos relacionados
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
WO2015061500A1 (en) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Mrna therapy for argininosuccinate synthetase deficiency
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
US9629804B2 (en) 2013-10-22 2017-04-25 Shire Human Genetic Therapies, Inc. Lipid formulations for delivery of messenger RNA
KR20250005450A (ko) 2014-04-25 2025-01-09 샤이어 휴먼 지네틱 테라피즈 인크. 메신저 rna 의 정제 방법
US10022455B2 (en) 2014-05-30 2018-07-17 Translate Bio, Inc. Biodegradable lipids for delivery of nucleic acids
MX389802B (es) 2014-06-24 2025-03-12 Shire Human Genetic Therapies Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos.
EP3164379A1 (en) 2014-07-02 2017-05-10 Massachusetts Institute of Technology Polyamine-fatty acid derived lipidoids and uses thereof
CA3054062A1 (en) 2017-02-27 2018-08-30 Translate Bio, Inc. Novel codon-optimized cftr mrna
MA49138A (fr) 2017-05-16 2020-03-25 Translate Bio Inc Traitement de la fibrose kystique par administration d'arnm à codons optimisés codant pour la cftr
CN112930396B (zh) 2018-08-24 2024-05-24 川斯勒佰尔公司 用于纯化信使rna的方法
WO2020106946A1 (en) 2018-11-21 2020-05-28 Translate Bio, Inc. TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

Also Published As

Publication number Publication date
BE640639A (en:Method) 1964-05-29
GB1072118A (en) 1967-06-14

Similar Documents

Publication Publication Date Title
CH422744A (de) Verfahren zur Herstellung neuer Polyoxyalkylenderivate
CH477448A (de) Verfahren zur Herstellung neuer Imidazolinderivate
AT258875B (de) Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate
AT244965B (de) Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptan-Derivate
CH455828A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH475266A (de) Verfahren zur Herstellung neuer Benzoazacycloalkene
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
AT248030B (de) Verfahren zur Herstellung neuer 5'-Sulfoxyde
AT260202B (de) Verfahren zur Herstellung neuer Dibenzocycloheptaenverbindungen
CH407092A (de) Verfahren zur Herstellung basischer Fluoren-Derivate
CH437278A (de) Verfahren zur Herstellung neuer Oestranderivate
CH404674A (de) Verfahren zur Herstellung neuer 3-Alkenyl- und 3-Alkinyl-1-(5-nitrofurfuryliden-amino)-hydantoine
CH464206A (de) Verfahren zur Herstellung von -Aminobenzylpenicillinen
AT265520B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH448049A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
CH407119A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH450448A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH480356A (de) Verfahren zur Herstellung neuer Azaphenthiazinderivate
AT251777B (de) Verfahren zur Herstellung neuer Hendekapeptide
CH423050A (de) Verfahren zur Herstellung neuer Diacylaminoanthrachinone
CH420172A (de) Verfahren zur Herstellung neuer 5-Nitrofurylverbindungen
AT243795B (de) Verfahren zur Herstellung neuer Chinolizin-Derivate
CH410950A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH420167A (de) Verfahren zur Herstellung neuer N-Diphenylalkyl-norgranatan- und -nortropan-Derivate
AT248032B (de) Verfahren zur Herstellung neuer 3α-Phenyl-granatan-Derivate